Corvus Pharmaceuticals enters sub-sublease for 20,916 sq ft in South San Francisco

Corvus Pharmaceuticals, Inc.

Sublease term of 36 months from later of consent or Feb 1, 2025; option to extend up to May 2030.
Monthly base rent ranges $33,833 to $47,200 over lease term; prepaid rent of $231,235 applied to first three months.
Security deposit of $75,000 required; triple net lease with Subtenant paying proportionate share of expenses.
Premises at 901 Gateway Boulevard, South San Francisco, comprising third floor and first floor space.
Sublease is from NewLimit under existing prime sublease from Theravance Biopharma.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.